Log in to save to my catalogue

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antip...

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antip...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2490302620

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics

About this item

Full title

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2020-11, Vol.80 (17), p.1763-1781

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Fasting hyperglycemia, impaired glucose tolerance, prediabetes, and diabetes are frequently present in patients treated with second-generation antipsychotics (SGAPs) for schizophrenia, bipolar disorder, and other severe mental illnesses. These drugs are known to produce weight gain, which may lead to insulin resistance, glucose intolerance, and met...

Alternative Titles

Full title

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2490302620

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2490302620

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-020-01393-x

How to access this item